Tag: life sciences
-
Trial to Test Radio Waves to Treat Alzheimer’s
A clinical trial is inviting individuals with Alzheimer’s disease to test a device that its designers claim can reverse cognitive impairment resulting from Alzheimer’s disease.
-
Ostrich Antibodies to Fight Resistant Infections
A biotechnology company developing antibodies grown in ostrich eggs is partnering with a Boston hospital to test a new treatment for Clostridium difficile, or C. difficile, a stubborn infection, increasingly resistant to antibiotics, and often contracted in hospitals.
-
High Leukemia Remissions Reported for Engineered T-Cells
First results from an international clinical trial of engineered immune system cells to treat leukemia in children show high rates of remission, but also many severe adverse effects.
-
U.S. Public Divided Over GM, Organic Food
The American public is almost evenly divided about the benefits of genetically-modified and organic food, with those divisions not breaking along easily defined or familiar lines.
-
Biotech to Earn Up to $1 Billion from Synthetic Peptides
A biotechnology enterprise designing synthetic peptides to treat a range of diseases could gain up to $1 billion or more in a licensing deal with the pharmaceutical company AstraZeneca.
-
Stem Cell Therapy Shows Early Results with Multiple Myeloma
First results from an early clinical trial show some patients with multiple myeloma receiving replacement blood-forming stem cells achieved at least a partial response and did not suffer severe adverse effects.
-
Room-Temperature Vaccine Storage Techniques Devised
Vaccines against viral diseases today need to be kept refrigerated to prevent spoilage, which raises costs and often prevents their widespread use in many developing regions. A team of materials scientists at Ecole polytechnique fédérale de Lausanne in Switzerland, or EPFL, proposes methods for storing vaccines without refrigeration for many days.
-
Company Launches to Discover Gut-Brain Therapies
A California Institute of Technology biologist is starting a new enterprise to discover treatments for neurological disorders through pathways originating in the gut.
-
Regeneron, Children’s National Partner on Rare Diseases
Regeneron Genetics Center and Children’s National Health System have begun studying thousands of genetic profiles to better understand the causes of rare and undiagnosed disorders.
-
Biodegradable Capsule Designed for Hemophilia Drug
A chemical engineering group designed a capsule to deliver blood coagulating proteins for people with hemophilia B who now require injections or infusions.